Ratings by Mizuho (Uy Ear)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/12/2024 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
23.44 (16.69) |
-28.8% | Details | |
| 3/12/2024 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
23.44 (23.44) |
0% | Details | |
| 3/4/2024 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/28/2024 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2024 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2024 | IN8bio Inc. | INAB | New Coverage | Buy (N/A) |
1.22 (1.03) |
-15.57% | Details | |
| 1/10/2024 | Arcutis Biotherapeutics Inc. | ARQT | Upgrade | Buy (Neutral) |
4.05 (8.88) |
119.26% | Details | |
| 1/3/2024 | Arcutis Biotherapeutics Inc. | ARQT | Upgrade | Buy (Neutral) |
3.23 (8.88) |
174.92% | Details | |
| 1/3/2024 | Arcutis Biotherapeutics Inc. | ARQT | Upgrade | Buy (Neutral) |
3.23 (8.88) |
174.92% | Details | |
| 12/28/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | uniQure BV | QURE | Downgrade | Neutral (Buy) |
8.27 (4.60) |
-44.38% | Details | |
| 12/18/2023 | Avrobio Inc. | AVRO | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | Avrobio Inc. | AVRO | Downgrade | Neutral (Buy) |
1.36 (1.19) |
-12.5% | Details | |
| 11/6/2023 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Neutral) |
24.07 (16.69) |
-30.66% | Details | |
| 11/6/2023 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Neutral) |
22.99 (16.69) |
-27.4% | Details | |
| 10/26/2023 | Arcutis Biotherapeutics Inc. | ARQT | Downgrade | Neutral (Buy) |
2.39 (8.88) |
271.55% | Details | |
| 9/25/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2023 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2023 | Avrobio Inc. | AVRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2023 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2023 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Ocugen, Inc. | OCGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2022 | Ocugen, Inc. | OCGN | Maintain | Buy (Buy) |
|
Details | ||
| 8/26/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2022 | Ocugen, Inc. | OCGN | New Coverage | Buy (N/A) |
2.45 (1.21) |
-50.61% | Details | |
| 6/28/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (Buy) |
|
Details | ||
| 6/24/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
| 5/25/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (Buy) |
|
Details | ||
| 5/6/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (Buy) |
|
Details | ||
| 5/3/2022 | Arcutis Biotherapeutics | AQRT | Maintain | Buy (Buy) |
|
Details | ||
| 4/7/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (Buy) |
|
Details | ||
| 3/23/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | Selecta Biosciences | SELB | Maintain | Buy (Buy) |
|
Details | ||
| 2/9/2022 | Avrobio Inc. | AVRO | Maintain | Buy (Buy) |
|
Details | ||
| 2/1/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (Buy) |
|
Details | ||
| 1/20/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (Buy) |
|
Details | ||
| 1/18/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (Buy) |
|
Details | ||
| 1/5/2022 | Avrobio Inc. | AVRO | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2021 | uniQure BV | QURE | New Coverage | Buy (N/A) |
27.85 (4.60) |
-83.48% | Details | |
| 12/2/2021 | Selecta Biosciences | SELB | New Coverage | Buy (N/A) |
3.00 (0.88) |
-70.67% | Details | |
| 12/2/2021 | Sarepta Therapeutics | SRPT | New Coverage | Buy (N/A) |
80.81 (117.64) |
45.58% | Details | |
| 12/2/2021 | Avrobio Inc. | AVRO | New Coverage | Buy (N/A) |
3.84 (1.19) |
-69.01% | Details | |
| 6/30/2021 | Arcutis Biotherapeutics Inc. | ARQT | New Coverage | Buy (N/A) |
27.05 (8.88) |
-67.17% | Details |
